iPSC-based Drug Discovery and Development Team
Team Leader Haruhisa INOUE, M.D.,Ph.D.
Disease modeling and drug discovery using disease-specific iPS cells in RIKEN BRC cell bank
Ref:Inoue et al., The EMBO Journal,2014
Induction of various types of cells from patient iPS cell
Accelerate open innovation for drug discovery in collaboration with outside partners
Back up RIKEN BRC cell bank in emergency
Recapitulate and Verify disease phenotypes
Develop cellular-level disease phenotypes
Evaluate potential drugs using patient cells